Boston Common Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Boston Common Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$738K	Hold	53,275	–	–	0.05%	148
2025 Q4	$748K	Hold	53,275	–	–	0.05%	155
2025 Q3	$745K	Hold	53,275	–	–	0.02%	256
2025 Q2	$801K	Hold	53,275	–	–	0.02%	259
2025 Q1	$703K	Buy	53,275 +35,210	+195%	+$486K	0.02%	258
2024 Q4	$285K	Buy	18,065 +3,140	+21%	+$47.2K	0.01%	283
2024 Q3	$237K	Hold	14,925	–	–	0.01%	301
2024 Q2	$227K	Sell	14,925 -91,965	-86%	-$1.32M	0.01%	305
2024 Q1	$1.57M	Hold	106,890	–	–	0.04%	262
2023 Q4	$1.49M	Buy	106,890 +14,450	+16%	+$193K	0.03%	260
2023 Q3	$1.24M	Buy	92,440 +8,675	+10%	+$117K	0.03%	255
2023 Q2	$1.06M	Hold	83,765	–	–	0.02%	257
2023 Q1	$954K	Hold	83,765	–	–	0.02%	256
2022 Q4	$867K	Hold	83,765	–	–	0.04%	171
2022 Q3	$877K	Sell	83,765 -19,970	-19%	-$213K	0.05%	169
2022 Q2	$1.15M	Buy	103,735 +26,770	+35%	+$291K	0.06%	167
2022 Q1	$858K	Buy	76,965 +1,975	+3%	+$22.4K	0.04%	177
2021 Q4	$981K	Buy	74,990 +17,500	+30%	+$221K	0.04%	175
2021 Q3	$749K	Buy	57,490 +10,350	+22%	+$138K	0.03%	182
2021 Q2	$693K	Sell	47,140 -10,360	-18%	-$145K	0.03%	195
2021 Q1	$706K	Buy	+57,500	New	+$739K	0.04%	186
2020 Q2	–	Sell	-81,360	Closed	-$656K	–	220
2020 Q1	$656K	Hold	81,360	–	–	0.09%	157
2019 Q4	$660K	Buy	81,360 +3,360	+4%	+$26.5K	0.08%	167
2019 Q3	$591K	Hold	78,000	–	–	0.07%	156
2019 Q2	$585K	Buy	78,000 +6,050	+8%	+$47.6K	0.07%	159
2019 Q1	$583K	Hold	71,950	–	–	0.08%	155
2018 Q4	$543K	Buy	71,950 +10,850	+18%	+$76.3K	0.08%	147
2018 Q3	$423K	Hold	61,100	–	–	0.05%	168
2018 Q2	$393K	Buy	+61,100	New	+$385K	0.05%	165
2014 Q3	–	Sell	-1,125	Closed	-$10K	–	306
2014 Q2	$10K	Hold	1,125	–	–	﹤0.01%	337
2014 Q1	$10K	Buy	+1,125	New	+$9.79K	﹤0.01%	371
2013 Q4	–	Sell	-1,125	Closed	-$9K	–	342
2013 Q3	$9K	Hold	1,125	–	–	﹤0.01%	387
2013 Q2	$9K	Buy	+1,125	New	+$8.21K	﹤0.01%	370